Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.
Press releases published on April 14, 2025
Unisize, a sizing recommendation software for fashion apparel e-commerce, releases a new demo of “FaceChange” AI Function
GlobeNewswire
·
April 14, 2025
LONDON, April 14, 2025 (GLOBE NEWSWIRE) -- Makip London., Ltd. has updated its sizing recommendation software - Unisize - and released a new feature that allows online shoppers to replace the facial features of the online model with their own face, …
ASML reports transactions under its current share buyback program
GlobeNewswire
·
April 14, 2025
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …
STMicroelectronics Announces Status of Common Share Repurchase Program
GlobeNewswire
·
April 14, 2025
STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from Apr 07, 2025 to Apr 11, 2025 AMSTERDAM – April 14, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a …
Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics
GlobeNewswire
·
April 14, 2025
DUBLIN and CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and …
Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
GlobeNewswire
·
April 14, 2025
BOSTON and ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …
Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)
GlobeNewswire
·
April 14, 2025
– Recognizes potential of off-the-shelf CAR T-cell therapy to address significant unmet need and enables increased dialogue with FDA throughout the development process – RMAT review by FDA included initial clinical safety and activity data from ongoing …
Western Uranium & Vanadium Corp. Announces Ore Purchase Agreement
GlobeNewswire
·
April 14, 2025
Toronto, Ontario and Nucla, Colorado, April 14, 2025 (GLOBE NEWSWIRE) -- Western Uranium …
Bitcoin 2.0: BloomBeans Offers $150M Airdrop for a New Economic Foundation
GlobeNewswire
·
April 14, 2025
Lisbon, Portugal, April 14, 2025 (GLOBE NEWSWIRE) -- BloomBeans.io is releasing the first decentraliced financial system to substitute Bitcoin. A New Global Financial System Lead by Takashi Nakamoto and designed by Austrian economists, BloomBeans operates …
Swarm Joins Hivello—Marking the 10th DePIN Network Aggregated
GlobeNewswire
·
April 14, 2025
LONDON and AMSTERDAM, April 14, 2025 (GLOBE NEWSWIRE) -- Hivello, a DePIN aggregator that enables users to earn by monetizing idle computer resources across multiple DePINs (Decentralized Physical Infrastructure Networks), has officially integrated Swarm …
American Tungsten Corp. Announces New CEO, Ali Haji
GlobeNewswire
·
April 14, 2025
Vancouver, BC, April 14, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) today announces that Ali Haji has been appointed as Chief Executive Officer. Murray Nye will assume the role …
Avicanna Reports Full Year 2024 Audited Financial Statement
GlobeNewswire
·
April 14, 2025
2024 Revenue of $25.5M, a 52% increase from 2023 Consolidated Gross Margins of 51%, Gross Profits of $12.9M, a 94% increase from 2023 TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: …
ECARX Unveils ECARXperience: Revolutionizing In-Vehicle Interaction with Adaptive AI-Powered Driving Experience
GlobeNewswire
·
April 14, 2025
SHANGHAI, April 14, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced the launch of ECARXperience, an advanced generative in-vehicle HMI system powered by its proprietary …
SynOx Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT)
GlobeNewswire
·
April 14, 2025
DUBLIN, Ireland and OXFORD, United Kingdom, April 14, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced that …
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
GlobeNewswire
·
April 14, 2025
Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry Significantly Elevates Lifecore’s Capabilities Across Corporate Governance, Transactional Activities, and …
ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
GlobeNewswire
·
April 14, 2025
LEIDEN, Netherlands …
ECARX to Report First Quarter 2025 Financial Results on April 30, 2025
GlobeNewswire
·
April 14, 2025
SHANGHAI, April 14, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings, Inc. (Nasdaq: ECX) ("ECARX"), a global mobility tech provider, today announced that it will report its financial results for the first quarter of 2025, before the U.S. market opens on Wednesday, …
Aya Gold & Silver Announces Appointment of John Burzynski to the Board and Departure of Nikolaos Sofronis
GlobeNewswire
·
April 14, 2025
MONTREAL, April 14, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce the appointment of Mr. John Burzynski to its Board of Directors as an Independent Director, effective …
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer
GlobeNewswire
·
April 14, 2025
25+ years of experience in executive leadership roles and developing global strategic growth plans with repeatable models applicable across markets, categories and channels Current President and CEO, Gilles Gagnon to remain as a Strategic Advisor and …
Calibre Delivers 71,539 Ounces in Q1 2025, a Record First Quarter Production; Provides Valentine Gold Mine Update
GlobeNewswire
·
April 14, 2025
VANCOUVER, British Columbia, April 14, 2025 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (the "Company" or "Calibre") is pleased to announce operating results for the three months (“Q1”) ended March 31, 2025, and an update on the …
CIRRO Fulfillment becomes an Associate Member of Baby Products Industry Association (BPIA) in the UK
GlobeNewswire
·
April 14, 2025
BIRMINGHAM, United Kingdom, April 14, 2025 (GLOBE NEWSWIRE) -- CIRRO Fulfillment, a global e-commerce fulfilment provider, proudly announces its new role as an Associate Member of the Baby Products Industry Association (BPIA), the leading voice of the UK …